Mantranews http://asktheturk.org/ Tue, 12 Oct 2021 13:03:27 +0000 en-US hourly 1 https://wordpress.org/?v=5.8 https://asktheturk.org/wp-content/uploads/2021/06/icon-100x100.png Mantranews http://asktheturk.org/ 32 32 The nation can only move forward through innovation and research: Minister of Health of Karnataka https://asktheturk.org/the-nation-can-only-move-forward-through-innovation-and-research-minister-of-health-of-karnataka/ Tue, 12 Oct 2021 12:45:52 +0000 https://asktheturk.org/the-nation-can-only-move-forward-through-innovation-and-research-minister-of-health-of-karnataka/

Karnataka Health Minister K Sudhakar said on Tuesday that a nation can only move forward through innovation and research and urged universities to prioritize research activities. He was speaking after the inauguration of the new digital learning management system at the Institute of Cardiovascular Science and Research in Jayadeva.

“Our universities should focus on research and development. It was the University of Oxford that developed the vaccine against COVID-19. There are many medical schools, but the focus should be on improving the quality of teaching and learning. Many students want to be a doctor, but only a few are ready to go into research. This must change, ”said the Minister. He said Prime Minister Narendra Modi has taken the initiative to establish the Indian Institute of Medical Sciences (AIIMS) in each state and the state government is also committed to providing quality health care at the district level of Karnataka.

“So we are creating four new medical schools. We also recently launched the Atal Bihari medical school,” he added. He stressed that every district must have a quality cardiac care facility.

“The Jayadeva Institute has grown on a par with any other corporate hospital. Patients receive excellent health care here. We have to think about why not all public hospitals can provide the same quality health care to people. Every public hospital, every government doctor must consider Jayadeva as a model and improve the quality of service, ”said the minister. (ANI)

(This story was not edited by Devdiscourse staff and is auto-generated from a syndicated feed.)


Source link

]]>
Private hospital in Gurugram booked for medical negligence, overcharging | News from Gurgaon https://asktheturk.org/private-hospital-in-gurugram-booked-for-medical-negligence-overcharging-news-from-gurgaon/ Tue, 12 Oct 2021 02:44:00 +0000 https://asktheturk.org/private-hospital-in-gurugram-booked-for-medical-negligence-overcharging-news-from-gurgaon/ GURUGRAM: A private DLF-3 hospital has been booked for alleged medical negligence and overcharging of a Covid-19 patient.
The hospital is accused of negligence in the treatment of the patient, which would have led to his infection with mucormycosis (black fungus). The hospital also allegedly overcharged him for oxygen and medication.
Gaurav Kumar (31) was admitted to DLF-3’s RBS Nathupur Hospital on May 5 in the Covid intensive care unit (without ventilator). His family alleged that proper treatment was not provided to him and that due to excessive administration of steroids, unsanitary oxygen equipment and negligent conduct of the hospital, Kumar developed a black fungus.
TOI contacted RBS Hospital for comment but did not get a response.
“The hospital illegally charged Rs 6,000 per day for the oxygen supply in violation of government standards. At that time, the government had set the price at Rs 8,000 per day for Covid intensive care (without ventilator) in private hospitals. The hospital, in collusion with its pharmacy, robbed the patient’s family and charged around Rs 85,000 for drugs purchased at his pharmacy, ”said Amit Sahni, the patient’s family lawyer.
The family alleged that although Kumar was admitted to hospital on May 5, he was unlawfully charged with drugs from May 4. “We are concerned that the drugs mentioned in the bill have not been administered to the patient, because the patient has not recovered from Covid to date despite such large doses of drugs,” said a relative .
On May 7, the patient had a nosebleed and doctors gave him injections to stop the bleeding. He later developed nasal obstruction and had difficulty breathing. “We complained about the nasal obstruction to the hospital staff and the doctor, but they ignored it and suggested inhaling steam. The nasal obstruction worsened, but the RBS doctors paid no attention. Large doses of steroids continued to be administered, ”the family member added.
Unable to get satisfactory treatment for the nasal obstruction, Kumar was transferred to the hospital in Paras on May 10, where doctors confirmed he had a black fungus in the nasal area. Kumar underwent surgery for mucormycosis on May 13. The patient is still admitted to the hospital in Paras and is undergoing treatment for black fungus and other related infections that are believed to have been caused during treatment with RBS. “We are under enormous financial pressure as the black fungus has developed due to the negligence of the RBS hospital,” the parent said.
Kumar’s family lodged a complaint with the police in July, but no FIR was filed. They then went to court. On October 1, Chief Justice Anil Kaushik ordered the police to register an FIR. A complaint was eventually filed against RBS Hospital and others, which have not yet been identified, under Articles 420 (deception) and 338 (negligent act endangering human life) of the IPC in the DLF-2 police station on Sunday.


Source link

]]>
ENC Pharmacists Explain How Merck’s COVID-19 Pill Works https://asktheturk.org/enc-pharmacists-explain-how-mercks-covid-19-pill-works/ Tue, 12 Oct 2021 00:03:00 +0000 https://asktheturk.org/enc-pharmacists-explain-how-mercks-covid-19-pill-works/

NEW BERN, NC (WITN) – Drugmaker Merck has asked the Federal Drug Administration for emergency use of its COVID-19 antiviral pill.

Earl Temple, a resident of Craven County, responded to Merck’s request by saying “I think that would be a great idea.”

The move makes Merck the first-ever pharmaceutical company to seek approval following promising Phase 3 clinical trials.

Anna Baird, clinical pharmacist at Realo Drugs in New Bern, explained that the drug works by inserting itself into the genetic material of the virus.

“It keeps it from replicating and as the virus replicates, that’s when it makes us sick. So when it fits into RNA, it can’t replicate itself and doesn’t make us sick anymore.

Baird said the process is similar to other drugs that have been on the market for years like Valtrex, which is used to treat herpes.

“I think it can be heartwarming for a lot of patients to know that this is not a new technology, it is not a new idea, it is something that has been used successfully against viruses,” he said. she declared.

While the COVID-19 vaccine works to prevent people from contracting the virus in the first place, there may soon be a new way to help those already diagnosed.

“It will reduce the burden on our health care system and keep people out of the hospital, it gives them a treatment option for the home,” Baird said.

Amy Copley is a pharmacist at CarolinaEast Medical Center. She said the pill could be a good option for people who cannot get the COVID-19 vaccine due to health reasons.

If approved, Merck’s COVID-19 antiviral pill could be available to Americans as soon as the end of the year.

Copyright 2021 WITN. All rights reserved.


Source link

]]>
Merck asks US FDA to clear promising anti-COVID pill https://asktheturk.org/merck-asks-us-fda-to-clear-promising-anti-covid-pill/ Mon, 11 Oct 2021 18:30:00 +0000 https://asktheturk.org/merck-asks-us-fda-to-clear-promising-anti-covid-pill/

Drugmaker Merck on Monday asked U.S. regulators to clear its pill to treat COVID-19 in what would add an entirely new and easy-to-use weapon to the global arsenal against the pandemic.

If cleared by the Food and Drug Administration – a decision that could come in a few weeks – it would be the first pill shown to treat the disease. All other FDA-backed COVID-19 treatments require an intravenous or injection.

An antiviral pill that people could take at home to reduce symptoms and speed recovery could prove revolutionary, ease the overwhelming workload on U.S. hospitals, and help curb epidemics in poorer countries with health systems. weak health. It would also strengthen the two-pronged approach to the pandemic: treatment, through drugs, and prevention, mainly through vaccination.

The FDA will review the company’s data on the safety and effectiveness of the drug, molnupiravir, before making a decision.

Merck and its partner Ridgeback Biotherapeutic said they have specifically asked the agency to grant emergency use to adults with mild to moderate COVID-19 who are at risk of serious illness or hospitalization. This is pretty much how COVID-19 infusion drugs are used.

“The value here is that it’s a pill, so you don’t have to worry about infusion centers and all the factors around them,” said Dr. Nicholas Kartsonis, senior vice president. from Merck’s Infectious Diseases Unit. “I think it’s a very powerful tool to add to the toolbox.

The company reported earlier this month that the pill halved hospitalizations and deaths in patients with early symptoms of COVID-19. The results were so strong that independent medical experts overseeing the trial recommended stopping it early.

Side effects were similar between patients who received the drug and those in a test group who received a dummy pill. But Merck has not publicly detailed the types of issues reported, which will be a key part of the FDA’s review.

Senior U.S. health officials continue to promote vaccinations as the best way to protect against COVID-19.

“It’s much, much better to keep yourself from getting infected than it is to have to treat an infection,” Dr Anthony Fauci said when discussing Merck’s drug last week.

Yet some 68 million eligible Americans remain unvaccinated, underscoring the need for effective drugs to control future waves of infection.

The prospect of a COVID-19 pill comes among other encouraging signs: New cases per day in the United States fell below 100,000 on average for the first time in more than two months, and deaths are d ‘about 1,700 a day, compared to more than 2,000 three weeks ago.

In addition, the average number of vaccines dispensed per day has exceeded one million, an increase of over 50% over the past two weeks, due to the introduction of reminders and vaccine requirements at the point of care. job.

Still, health officials are bracing for another possible flare as the cold pushes more people inside.

Since the start of the pandemic, health experts have stressed the need for a practical pill. The goal is something similar to Tamiflu, the 20-year-old flu medicine that shortens illness by a day or two and alleviates the severity of symptoms like fever, cough, and stuffy nose.

Three antibody-based drugs cleared by the FDA have been shown to be very effective in reducing deaths from COVID-19, but they are expensive, difficult to produce, and require specialized equipment and medical professionals.

Assuming FDA clearance, the US government agreed to purchase enough pills to treat 1.7 million people, at a price of around $ 700 for each treatment. That’s less than half the price of antibody drugs bought by the US government – over $ 2,000 per infusion – but still more expensive than many antiviral pills for other conditions.

Merck’s Kartsonis said in an interview that the $ 700 figure does not represent the final price of the drug.

“We set this price before we had any data, so it’s just one contract,” Kartsonis said. “Obviously, we’re going to be responsible about it and making this drug as accessible as possible to as many people around the world as possible. “

Merck, based in Kenilworth, New Jersey, said it was in purchasing talks with governments around the world and would use a sliding price scale based on each country’s economic means. In addition, the company has signed licensing agreements with several Indian generic drug manufacturers to produce low-cost versions of the drug for low-income countries.

Several other companies, including Pfizer and Roche, are studying similar drugs and are expected to release results in the coming weeks and months. AstraZeneca is also seeking FDA clearance for a long-acting antibody drug designed to provide months of protection for patients with immune system disorders and not responding adequately to vaccination.

Some experts predict that various COVID-19 therapies will eventually be prescribed in combination to better protect against the worst effects of the virus.


Source link

]]>
World Arthritis Day 2021 | Arthritis Myths and Facts https://asktheturk.org/world-arthritis-day-2021-arthritis-myths-and-facts/ Mon, 11 Oct 2021 12:47:42 +0000 https://asktheturk.org/world-arthritis-day-2021-arthritis-myths-and-facts/

World Arthritis Day 2021: Rheumatic ailments have existed since ancient times and are even mentioned in Ayurvedic texts. Arthritis causes significant morbidity, poor quality of life and affects a person’s productivity, resulting in loss of livelihood and increasing the socio-economic burden on our society.Also read – What is cerebral palsy? Symptoms, Causes Treatment, Explained | Watch the video

Dr Aneesa Kapadia, DNB (Gen Med), MRCPUK, SCE in Consultant Rheumatologist, Masina Hospital sheds light on the myths and facts about arthritis. Also Read – Foods That Boost Mood: These Healthy Foods That Can Immediately Improve Your Mood | Watch the video

Arthritis literally means painful inflammation and stiffness in the joints that cause disease. Also Read – Signs And Symptoms Of Breast Cancer In Addition To The Lump

Myth 1: Arthritis only affects the elderly?

Arthritis can affect patients of any age group. Young children, adults in their prime as well as the elderly can be affected by arthritis.

Myth 2: My family member has arthritis, will I have it too?

Some conditions, especially ankylosing spondylitis, psoriatic arthritis, and lupus, affect multiple family members. However, this is never 100% and should not cause premature worry as there is no way to predict it.

Myth 3: Acidic foods make arthritis symptoms worse

This is a very common misconception. There is no evidence that acidic foods make arthritis worse, and you don’t need to avoid these foods. Only patients with gout should avoid certain foods such as red meat, seafood, alcoholic beverages, and other foods containing purines.

Myth 4: My hands and feet will deform

Untreated arthritis can lead to deformities. However, with early diagnosis and treatment, it can be avoided. Most arthritis patients lead functional and productive lives.

Myth 5: There is no cure for arthritis

Advances in medical science have led to the discovery of many new drugs. Some of these drugs are a game-changer in the treatment of rheumatic diseases. When used properly under expert supervision and supervision, most patients do very well. Adverse events, when noted, are related to long-term use of pain relievers and steroids which can be avoided if the right drugs are started at the right time.

Fact 1: There is no cure for arthritis in any branch of medicine

Arthritis like any other chronic disease eg diabetes, hypertension, thyroid disorder cannot be cured. However, drugs can provide very good control so that the patient can live a normal and pain-free life.

Fact 2: Medication May Be Needed Long Term

Although the drugs will need to be taken long term, the doses may be reduced once the disease is controlled. Natural remission can occur and if it does, the drugs can be stopped. However, this is extremely individualized and depends on patient to patient.

Fact 3: Non-medical measure for the treatment of arthritis.

Regular exercise, eating a healthy and balanced diet, and maintaining a normal body weight can go a long way in delaying or controlling your arthritis.


Source link

]]>
Pennsylvania Senator Introduces Bill to Legalize Marijuana | News, Sports, Jobs https://asktheturk.org/pennsylvania-senator-introduces-bill-to-legalize-marijuana-news-sports-jobs/ Mon, 11 Oct 2021 06:31:08 +0000 https://asktheturk.org/pennsylvania-senator-introduces-bill-to-legalize-marijuana-news-sports-jobs/

Legalized marijuana for adult use in Pennsylvania has won another Republican supporter.

Senator Mike Regan, R-Cumberland / York, circulated a co-sponsorship memorandum signaling Regan’s intention to introduce legislation legalizing adult-use marijuana in the state. Regan explained his reasoning in a weekend guest essay distributed to newspapers in his Senate district.

Regan helped draft the state’s medical marijuana program in 2016 while he was a member of the state House of Representatives, noting that 500,000 people in Pennsylvania have received medical marijuana prescriptions since then.

“I want to build on the success of this program while ensuring its continued viability for the industry and its patients.

I also want to make sure that Pennsylvanians get their fair share of selling adult marijuana, not cartels and gangs whose profits are comparable to Fortune 500 companies, ”Regan wrote in her editorial.

Regan’s bill, which has yet to be tabled, would legalize use by adults 21 and older, establish a new regulatory oversight board much like the New York program, and remove penalties for it. adult use and possession of marijuana. Those who buy marijuana would see no change in their ability to buy guns. Regan also said his legislation would deal with DUI enforcement and develop education and deterrents for use and possession by minors.

According to the Regan legislative memorandum, which Regan filed on Monday, the money raised by his marijuana legalization program would benefit in part the Pennsylvania state police and invest in the state’s roads and bridges.

Pennsylvania Republicans have generally opposed marijuana legalization bills, some of which have been introduced since the early 1980s by Democrats. Governor Tom Wolf and Lieutenant Governor John Fetterman have expressed their support for bills to legalize marijuana.

“For those who question my sponsorship of such legislation, it is important to recognize that the legalization of adult marijuana in Pennsylvania is inevitable.” Regan wrote. “As chairman of the Senate Committee on Law and Justice and a former member of law enforcement, rather than sit idly by and allow others to shape the law, I am mobilizing to become a leader on the question, as I did on medical marijuana. And I do this using a sensible, two-party, bicameral approach that will allow Pennsylvanians to access a safe product, create thousands of jobs, level the playing field with neighboring states, support the forces of order and our communities, and more importantly, to fund the deadly drug cartels that have wreaked havoc in the Commonwealth and our country for so many years.

Earlier this year, Senator Dan Laughlin, R-Erie, became one of the first Republicans to publicly support the legalization of marijuana in the state. Laughlin and Sen. Sharif Street, D-Philadelphia, in February announced a joint plan to legalize adult cannabis, create a state-run system to grow and sell the drug, and clear records for related non-violent offenses cannabis. Laughlin and Street said the proposal also prioritizes license holders who have suffered disproportionately from the War on Drugs and encourages the growth of small operations.

“We will proceed with caution”, Laughlin said earlier this year. “It will take a lot of phone calls and emails to get through the committee process and stand for a vote. “

Legalized marijuana for adult use in Pennsylvania has won another Republican supporter.

Senator Mike Regan, R-Cumberland / York, circulated a co-sponsorship memorandum signaling Regan’s intention to introduce legislation legalizing adult-use marijuana in the state. Regan explained his reasoning in a weekend guest essay distributed to newspapers in his Senate district.

Regan helped draft the state’s medical marijuana program in 2016 while he was a member of the state House of Representatives, noting that 500,000 people in Pennsylvania have received medical marijuana prescriptions since then.

“I want to build on the success of this program while ensuring its continued viability for the industry and its patients.

I also want to make sure that Pennsylvanians get their fair share of selling adult marijuana, not cartels and gangs whose profits are comparable to Fortune 500 companies, ”Regan wrote in her editorial.

Regan’s bill, which has yet to be tabled, would legalize use by adults 21 and older, establish a new regulatory oversight board much like the New York program, and remove penalties for it. adult use and possession of marijuana. Those who buy marijuana would see no change in their ability to buy guns. Regan also said his legislation would deal with DUI enforcement and develop education and deterrents for use and possession by minors.

According to the Regan legislative memorandum, which Regan filed on Monday, the money raised by his marijuana legalization program would benefit in part the Pennsylvania state police and invest in the state’s roads and bridges.

Pennsylvania Republicans have generally opposed marijuana legalization bills, some of which have been introduced since the early 1980s by Democrats. Governor Tom Wolf and Lieutenant Governor John Fetterman have expressed their support for bills to legalize marijuana.

“For those who question my sponsorship of such legislation, it is important to recognize that the legalization of adult marijuana in Pennsylvania is inevitable.” Regan wrote. “As chairman of the Senate Committee on Law and Justice and a former member of law enforcement, rather than sit idly by and allow others to shape the law, I am mobilizing to become a leader on the question, as I did on medical marijuana. And I do this using a sensible, two-party, bicameral approach that will allow Pennsylvanians to access a safe product, create thousands of jobs, level the playing field with neighboring states, support the forces of order and our communities, and more importantly, to fund the deadly drug cartels that have wreaked havoc in the Commonwealth and our country for so many years.

Earlier this year, Senator Dan Laughlin, R-Erie, became one of the first Republicans to publicly support the legalization of marijuana in the state. Laughlin and Sen. Sharif Street, D-Philadelphia, in February announced a joint plan to legalize adult cannabis, create a state-run system to grow and sell the drug, and clear records for related non-violent offenses cannabis. Laughlin and Street said the proposal also prioritizes license holders who have suffered disproportionately from the War on Drugs and encourages the growth of small operations.

“We will proceed with caution”, Laughlin said earlier this year. “It will take a lot of phone calls and emails to get through the committee process and stand for a vote. “

The latest news today and more in your inbox


Source link

]]>
Professor of Pharmacy Roger Lander retires from Samford University after 35 years https://asktheturk.org/professor-of-pharmacy-roger-lander-retires-from-samford-university-after-35-years/ Sun, 10 Oct 2021 20:21:37 +0000 https://asktheturk.org/professor-of-pharmacy-roger-lander-retires-from-samford-university-after-35-years/

October 8, 2021

When he started in the fall of 1986, Lander was one of 16 faculty members hired that year, doubling the number of staff within the school. The school of pharmacy was in a season of expansion — pushing itself to be at the forefront of pharmacy education.

While Lander was initially hired for his pharmacokinetic background, he quickly became known as a jack of all trades. He has taught courses on subjects such as pharmacotherapy, cardiology and infectious diseases. “I was trained to be a general practitioner in adult medicine so I was able to do a bit of everything,” Lander said.

Lander also has a strong desire to help others be successful. “Roger was gracious in his willingness to abandon his teaching interests in an intentional effort to train younger teachers,” said Marshall cates, professor and chairman of the school’s pharmacy practice department. “He’s someone who has a natural instinct to mentor others, and we as teachers, as well as our students, have benefited.”

The origins of many academic and practical opportunities that students know today can be traced directly to Lander, including the establishment of practice sites at Brookwood Baptist Hospital, VA Hospital Birmingham, and the Jefferson County Department of Health. His work in the health department resulted in the development of a postgraduate pharmacy residency program, which was the first of its kind to be developed with a state or county health department.

Beyond his work for the McWhorter School of Pharmacy, his impact as a pharmacist and educator reaches a global level. In addition to playing a pivotal role in expanding the international engagement of pharmacy students at Samford, Lander has also worked to unite global communities on the topic of clinical pharmacy practice and education.

In 1995, Lander came up with the idea of ​​bringing together clinical pharmacists from Asian countries to share knowledge and ideas. As a result, he founded the Asian Conference on Clinical Pharmacy. Samford hosted the inaugural conference in 1997 with 36 international pharmacists, and it has grown significantly, becoming the largest clinical pharmacy conference in Asia.

The conference now takes place every year with over a thousand pharmacists in attendance, representing over 14 countries. Lander continues to serve on the organization’s board of directors.

“Dr. Lander has created a legacy at the McWhorter School of Pharmacy that is unmatched and that will last for generations,” said michael crouching, Dean of the McWhorter School of Pharmacy and Associate Dean of Samford’s College of Health Sciences. “We will miss him very much, but we wish him the best in this new retirement season.”


This press release was produced by Samford University. The opinions expressed here are those of the author.


Source link

]]>
Mental health issues unrelated to allergies including asthma, hay fever https://asktheturk.org/mental-health-issues-unrelated-to-allergies-including-asthma-hay-fever/ Sun, 10 Oct 2021 17:21:00 +0000 https://asktheturk.org/mental-health-issues-unrelated-to-allergies-including-asthma-hay-fever/



ANI |
Update:
October 10, 2021 10:51 PM STI

Washington [US], Oct 10 (ANI): Researchers at Bristol Medical School: Population Health Sciences (PHS) and School of Psychological Science broke rumors and found that allergic diseases do not cause mental health traits, including anxiety, depression, bipolar disorder and schizophrenia or vice versa.
The results of the study were published in the journal “Clinical and Experimental Allergy”.
Allergic diseases such as asthma, atopic dermatitis and hay fever do not cause the onset of mental health problems or vice versa, according to the results of a new study conducted by the University of Bristol.
While previous studies have reported an observational relationship between mental health and common allergic diseases, until now the causal relationships have not yet been identified.
First, the team of researchers sought to isolate the effects of these allergic diseases by applying a scientific technique called Mendelian Randomization, which allowed them to identify genetic variants linked to these allergic diseases, and then studied how these variants were causally linked to the presence of mental disorders. health conditions based on a sample of 12,000 to 344,901 individuals.

Although the researchers identified observational associations between allergic diseases and mental health traits, these were not replicated in the team’s causal analysis. Little evidence of a causal relationship between the onset of allergic disease and mental health was found, suggesting that the observational associations found were due to confounding factors or other forms of bias.
The authors conclude that intervening during the initial presentation of an allergic disease is unlikely to improve mental health outcomes. Likewise, preventing the onset of mental health traits is unlikely to reduce the risk of allergic disease. However, more research is needed to determine whether intervening in the progression of allergic disease after its onset has a causal impact on mental health.
Dr Ashley Budu-Aggrey, Senior Research Associate at Bristol Medical School: PHS and lead author of the study said: “Common mental health disorders such as anxiety and depression are among the most important Contributors to the global disease burden and its allergic diseases have been on the rise for some time. Unraveling the nature of the relationship between allergic disease and mental health helps answer an important health question and suggests that the onset of allergic disease does not cause the onset of mental health traits or vice versa.
“However, this does not rule out a potential causal effect on disease progression that has not yet been studied and could help uncover new treatment strategies for allergic diseases or mental health traits,” added Dr Budu-Aggrey.
Lead author Dr Hannah Sallis, Senior Research Associate at the School of Psychological Science, Bristol, added: “The research used a combination of approaches and data from several studies. This helps to build our confidence in Determining whether allergic disease causes mental health problems, or vice versa, is important to ensure that resources and treatment strategies are targeted appropriately. “
The study was funded by grants from the Medical Research Council (MRC), the European Research Council (ERC), the National Institute for Health Research Bristol Biomedical Research Center (NIHR Bristol BRC), the Norwegian Research Council, the British Skin Foundation and the Academy of Medical Sciences. Springboard Award, which is supported by the Wellcome Trust, the Department for Business, Energy and Industrial Strategy, Global Challenges Research Fund and the British Heart Foundation. (ANI)


Source link

]]>
Karnataka NEET MDS Council 2021, Karnataka NEET MDS Council, Karnataka NEET Council 2021, KEA, kea.kar.nic.i https://asktheturk.org/karnataka-neet-mds-council-2021-karnataka-neet-mds-council-karnataka-neet-council-2021-kea-kea-kar-nic-i/ Sun, 10 Oct 2021 11:42:54 +0000 https://asktheturk.org/karnataka-neet-mds-council-2021-karnataka-neet-mds-council-karnataka-neet-council-2021-kea-kea-kar-nic-i/
Image source: PTI

The registration process for the Karnataka NEET MDS 2021 for the counseling session will end tomorrow.

Karnataka NEET MDS 2021: The Karnataka Examinations Authority (KEA) has initiated the online registration process for admission to postgraduate and graduate dental courses in the state. Applicants who have qualified in the NEET MDS 2021 can apply for the Karnataka State Quota Counseling Process at kea.kar.nic.in Where cetonline.karnataka.gov.in/kea.

Karnataka NEET MDS 2021: How to apply

  1. Go to the official website – kea.kar.nic.in
  2. Open the link ‘Online application (only for dental care)
  3. Save and generate login credentials
  4. Log in and submit the request form.

The Medical Advisory Committee (MCC) began registration for the second round of NEET MDS counseling for the 50 percent state quota seats. Registration, fee payment, pick filling and lockdown facilities will be available until October 11 and the seat assignment results will be released on October 14. The exam took place on December 16, 2020 and the results were announced on December 31, 2020.

NEET MDS is a national level entrance examination organized by the National Board of Examinations in Medical Sciences (NBEMS) for admission to postgraduate courses in dentistry.

READ MORE | NTA NEET UG 2021: response key to be published soon; important details here

READ MORE | Karnataka primary schools to reopen after Dussehra

Latest Education News


Source link

]]>
Editorial: From gloves to drugs, self-sufficiency takes off again in pandemic Virginia | Editorial https://asktheturk.org/editorial-from-gloves-to-drugs-self-sufficiency-takes-off-again-in-pandemic-virginia-editorial/ Sun, 10 Oct 2021 04:00:00 +0000 https://asktheturk.org/editorial-from-gloves-to-drugs-self-sufficiency-takes-off-again-in-pandemic-virginia-editorial/

In recent weeks, the Commonwealth has made major inroads on two medical fronts. In southwest Virginia, Northam announced on Monday that Blue Star NBR and American Glove Innovations plan to create 2,500 jobs over the next three to five years by manufacturing PPE at Progress Park in County Wythe. According to a statement from the governor’s office, the $ 714 million project would produce billions of gloves a year for healthcare, government, retail and hospitality customers.

“We felt there was a very timely opportunity not to depend on the whims of Asia when we have here in America all the skills, abilities and intelligence to be a market leader, self-sufficient. and highly competitive, ”Blue Star-AGI’s co-CEO Marc Jason said in a statement.

This economic development agreement was supported by $ 8.5 million in state infrastructure upgrades at Progress Park. These investments include a $ 3 million expansion of the Fort Chiswell sewage treatment plant, a $ 1.5 million expansion of public sewer infrastructure and $ 4 million for a new reservoir. water, all of which are expected to increase the future potential of creating more manufacturing jobs, the statement added.

Similar lessons from a pandemic are being applied in the pharmaceutical space. The leaders met at the end of September at the College of Engineering at the Commonwealth of Virginia University to discuss new legislation that would institute a national strategic stockpile of key ingredients for generic drugs, while prioritizing the manufacture here at home of those stocks. By a VCU press releaseGeneric drugs make up 90% of all prescriptions filled in the United States, but 87% of active pharmaceutical ingredient facilities for such treatments are housed in other countries.


Source link

]]>